Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -11.10%2.05B | -8.23%1.29B | 1.38%547.29M | 13.58%3.61B | 12.33%2.31B | 17.44%1.41B | 3.93%539.86M | -7.80%3.18B | -5.64%2.05B | -11.11%1.2B |
| Operating revenue | -11.10%2.05B | -8.23%1.29B | 1.38%547.29M | 13.58%3.61B | 12.33%2.31B | 17.44%1.41B | 3.93%539.86M | -7.80%3.18B | -5.64%2.05B | -11.11%1.2B |
| Other operating revenue | ---- | -20.51%50.15M | ---- | -14.62%108.03M | ---- | -4.17%63.08M | ---- | 0.49%126.53M | ---- | -2.63%65.83M |
| Total operating cost | -3.94%2.28B | -2.60%1.47B | -4.02%623.63M | -3.75%3.53B | -3.65%2.38B | 0.76%1.51B | -5.81%649.74M | -7.09%3.66B | -1.32%2.47B | -5.07%1.5B |
| Operating cost | -3.76%1.24B | -1.62%772.38M | 8.91%309.02M | 7.08%2.01B | 7.24%1.28B | 9.76%785.06M | 0.43%283.73M | -13.30%1.88B | -2.35%1.2B | -7.48%715.26M |
| Operating tax surcharges | 10.46%26.08M | 14.78%16.9M | 45.56%8.47M | 11.34%36.35M | 3.87%23.61M | -0.25%14.72M | -28.08%5.82M | 11.78%32.64M | 15.42%22.73M | 23.50%14.76M |
| Operating expense | -1.93%422M | 3.54%285.45M | -12.83%107.12M | -9.36%602.32M | -7.59%430.32M | 3.79%275.7M | -6.58%122.89M | -1.83%664.49M | -0.77%465.68M | -6.15%265.63M |
| Administration expense | -1.66%205.89M | -1.63%133.68M | -10.63%61.41M | -13.69%311.02M | -2.39%209.36M | 8.40%135.9M | -1.66%68.71M | 14.55%360.34M | 8.07%214.5M | -1.47%125.38M |
| Financial expense | -22.27%92.53M | -25.44%60.67M | -11.18%33.67M | -11.01%154.97M | -5.45%119.05M | -0.51%81.37M | -5.46%37.91M | -9.50%174.15M | 14.72%125.91M | 5.98%81.79M |
| -Interest expense (Financial expense) | -15.23%105.69M | -16.82%71.65M | -0.47%35.97M | -6.29%168.34M | 3.39%124.68M | -1.69%86.14M | -4.17%36.14M | -11.15%179.64M | -13.86%120.59M | -9.47%87.62M |
| -Interest Income (Financial expense) | -79.82%-12.84M | -67.93%-9.73M | 28.86%-2.27M | -55.07%-15.32M | -9.08%-7.14M | -13.28%-5.79M | -8.48%-3.19M | -19.11%-9.88M | -8.41%-6.55M | -20.09%-5.11M |
| Research and development | -3.04%301.75M | -7.13%202.7M | -20.47%103.93M | -25.75%412.73M | -29.51%311.21M | -26.47%218.26M | -17.12%130.68M | -1.85%555.84M | -7.49%441.51M | -3.40%296.84M |
| Credit Impairment Loss | 111.51%2.08M | 130.08%2.76M | 10.62%6.43M | 44.01%-39.35M | -752.30%-18.08M | -251.76%-9.17M | 1,284.39%5.81M | -361.62%-70.29M | 131.69%2.77M | 177.89%6.05M |
| Asset Impairment Loss | 50.04%-2.22M | -320.11%-7.83M | -234.61%-1.02M | 61.05%-40.97M | 14.14%-4.44M | 58.91%-1.86M | -49.10%755.25K | 42.39%-105.2M | -100.24%-5.18M | -108.10%-4.54M |
| Other net revenue | -18.77%152.49M | -15.79%108.5M | -19.07%46.9M | 63.33%169.28M | 17.76%187.72M | 30.41%128.85M | 69.31%57.95M | 2,286.09%103.65M | 49.35%159.4M | 53.83%98.8M |
| Fair value change income | -110.49%-56.43K | 1.86%485.43K | 181.31%92.34K | 228.84%2.73M | 30.69%537.98K | -84.24%476.58K | -96.30%32.82K | 130.43%829.68K | -61.93%411.64K | 218.12%3.02M |
| Invest income | -66.41%27.38M | -57.52%20.42M | -70.79%5.89M | -49.05%40.65M | 107.98%81.5M | 235.26%48.07M | 395.42%20.16M | 207.06%79.78M | 438.73%39.19M | 252.50%14.34M |
| -Including: Investment income associates | -148.40%-4.07M | -274.07%-6.84M | -320.76%-7.73M | -99.89%-18.65M | 187.02%8.41M | 124.99%3.93M | 83.65%-1.84M | 73.01%-9.33M | 34.60%-9.67M | -30.12%-15.72M |
| Asset deal income | 152.75%307.33K | 121.42%124.88K | 158.61%206.92K | -426.00%-722.55K | -118.30%-582.58K | -119.78%-583K | -86,048.21%-353.08K | 491.71%221.64K | -3,304.97%-266.87K | -1,412.45%-265.27K |
| Other revenue | -2.94%125M | 0.67%92.54M | 11.89%35.3M | 4.36%206.95M | 5.15%128.79M | 14.62%91.93M | -19.46%31.55M | 10.79%198.3M | -4.72%122.48M | -2.91%80.2M |
| Operating profit | -171.50%-82.31M | -341.17%-68.77M | 43.30%-29.44M | 168.23%257.52M | 144.91%115.13M | 114.28%28.51M | 61.85%-51.93M | 22.55%-377.41M | -16.84%-256.34M | -21.55%-199.72M |
| Add:Non operating Income | -20.01%4.72M | -72.93%1.15M | -84.43%407.45K | 57.40%12.7M | 43.05%5.9M | 27.36%4.24M | 555.48%2.62M | 117.36%8.07M | 367.94%4.13M | 344.67%3.33M |
| Less:Non operating expense | 670.95%8.91M | 134.34%7.6M | -91.64%154.45K | 117.86%9.9M | -69.01%1.16M | 228.60%3.24M | 315.80%1.85M | -77.77%4.55M | 150.17%3.73M | -34.81%986.79K |
| Total profit | -172.17%-86.51M | -354.85%-75.22M | 42.94%-29.19M | 169.63%260.32M | 146.84%119.87M | 114.95%29.52M | 62.43%-51.16M | 25.82%-373.88M | -16.33%-255.94M | -19.57%-197.37M |
| Less:Income tax cost | 45.46%11.67M | -3.60%5.04M | 337.51%3.75M | 211.44%33.86M | 121.47%8.02M | 118.87%5.23M | 95.31%-1.58M | 117.83%10.87M | 52.07%-37.37M | 49.04%-27.72M |
| Net profit | -187.78%-98.18M | -430.50%-80.26M | 33.57%-32.94M | 158.86%226.46M | 151.17%111.85M | 114.31%24.28M | 51.63%-49.58M | 13.15%-384.75M | -53.88%-218.57M | -53.30%-169.65M |
| Net profit from continuing operation | -187.78%-98.18M | -430.50%-80.26M | 33.57%-32.94M | 158.86%226.46M | 151.17%111.85M | 114.31%24.28M | 51.63%-49.58M | 13.15%-384.75M | -53.88%-218.57M | -53.30%-169.65M |
| Less:Minority Profit | -517.84%-35.84M | -39.91%-29.76M | 48.95%-12.41M | 131.55%19.6M | 86.30%-5.8M | 34.06%-21.27M | -60.14%-24.31M | 8.95%-62.1M | -29.68%-42.34M | -32.24%-32.26M |
| Net profit of parent company owners | -152.98%-62.34M | -210.86%-50.5M | 18.77%-20.53M | 164.11%206.86M | 166.76%117.65M | 133.16%45.56M | 71.06%-25.27M | 13.92%-322.65M | -61.10%-176.23M | -59.25%-137.39M |
| Earning per share | ||||||||||
| Basic earning per share | -153.85%-0.14 | -210.00%-0.11 | 16.67%-0.05 | 163.89%0.46 | 166.16%0.26 | 132.68%0.1 | 69.23%-0.06 | 14.29%-0.72 | -59.11%-0.393 | -56.92%-0.306 |
| Diluted earning per share | -153.85%-0.14 | -210.00%-0.11 | 16.67%-0.05 | 163.89%0.46 | 166.16%0.26 | 132.68%0.1 | 69.23%-0.06 | 14.29%-0.72 | -59.11%-0.393 | -56.92%-0.306 |
| Other composite income | 668.13%3.15M | 364.60%2.59M | 219.73%768.7K | -116.54%-352.55K | -158.55%-554.41K | -165.03%-977.11K | -2,692.74%-642.05K | -52.58%2.13M | 20.75%946.97K | 810.10%1.5M |
| Other composite income of parent company owners | 1,226.70%2.38M | 463.75%1.76M | 212.38%516.16K | -128.99%-418.6K | -125.41%-211.6K | -143.11%-483.05K | -180,715.93%-459.29K | -65.58%1.44M | -20.13%832.84K | 179.81%1.12M |
| Other composite income of minority owners | 323.36%765.7K | 267.66%828.31K | 238.19%252.54K | -90.39%66.05K | -400.38%-342.81K | -229.33%-494.05K | -845.68%-182.76K | 130.03%687.17K | 144.14%114.13K | 262.28%382.01K |
| Total composite income | -185.38%-95.03M | -433.27%-77.68M | 35.95%-32.17M | 159.09%226.1M | 151.14%111.29M | 113.86%23.31M | 50.99%-50.23M | 12.75%-382.62M | -54.06%-217.62M | -52.17%-168.15M |
| Total composite income of parent company owners | -151.05%-59.95M | -208.15%-48.74M | 22.22%-20.01M | 164.27%206.44M | 166.96%117.44M | 133.07%45.07M | 70.54%-25.73M | 13.33%-321.21M | -61.89%-175.39M | -58.69%-136.27M |
| Total composite income of minority owners | -470.91%-35.08M | -32.93%-28.93M | 50.37%-12.16M | 132.01%19.66M | 85.45%-6.14M | 31.72%-21.76M | -61.61%-24.5M | 9.56%-61.42M | -28.32%-42.23M | -29.43%-31.88M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.